Global $13.4 Billion Cannabidiol Market to 2028 - Increasing Awareness CBD Health Benefits, Changing Consumer Opinion, and Attitude Toward CBD Products

DUBLIN, March 24, 2021 /PRNewswire/ -- The "Cannabidiol Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global cannabidiol market size is expected to reach USD 13.4 billion by 2028. The market is expected to expand at a CAGR of 21.2% from 2021 to 2028.

Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth.

The recent COVID-19 pandemic has affected many industries around the world, including the CBD industry. The impact of COVID-19 has led to disruption in production processes, due to strict quarantine measures taken across the globe, there is a stagnation in the supply of products, including CBD products. In addition, most of the retail stores are currently closed due to the pandemic. Hence, the marketplace may face a slowdown amidst the pandemic, however, it can gain momentum in 2021, due to the increase in demand for CBD-based products in the coming years.

In 2020, the hemp segment accounted for the largest revenue share valued at USD 1.7 billion, owing to the rising awareness regarding the health benefits of products infused with cannabidiol derived from marijuana. On the other hand, hemp-derived CBD is expected to witness the fastest CAGR over the forecast period, owing to the increasing legalization of hemp in various countries.

The Business to Business (B2B) segment accounted for the largest revenue share in 2020 and is expected to witness a lucrative growth rate over the forecast period. Growing demand for cannabidiol products in various sectors such as health and wellness, pharmaceutical, food and additives, and cosmetics sectors has increased the need for companies to procure cannabidiol raw material or precursor material for their product in bulk. Hence, various growth opportunities are emerging in the cannabidiol wholesale business, which is expected to propel the growth of this segment.

North America dominated the market in 2020 and is expected to continue its dominance over the forecast period. Favorable regulations, increasing awareness about CBD oil, growing consumer preference, and a rise in the number of manufacturers are factors expected to fuel market growth in the region.

Cannabidiol Market Report Highlights

• North America accounted for the largest revenue share in 2020 owing to the increase in consumers opting for CBD oil and awareness about allied products
• Hemp-derived CBD dominated the market in 2020, with a revenue of USD 1.7 billion owing to its higher purity and potential health benefits
• The B2B segment accounted for the largest revenue share in 2020 owing to the increasing demand and rising number of businesses using cannabidiol as raw materials
• In 2020, the medical segment accounted for the largest revenue share owing to the rising use of cannabis derivate for various medical conditions

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 CBD Market Variables, Trends & Scope
3.1 Market Segmentation (Global Cannabidiol (CBD) Market)
3.2 Global Cannabis Extracts Trade Route
3.3 Global Cannabis Extracts Demand and Supply Analysis
3.4 Penetration & Growth Prospects Mapping
3.5 Cannabis Regulatory Scenario, By Country
3.5.1 U.S.
3.5.1.1 Cultivation/Production
3.5.1.2 Legal Status (CBD & THC)
3.5.1.3 Regulatory Bodies Involved
3.5.2 Canada
3.5.3 Germany
3.5.4 Italy
3.5.5 Croatia
3.5.6 Netherlands
3.5.7 Czech Republic
3.5.8 Poland
3.5.9 Switzerland
3.5.10 Australia
3.5.11 Israel
3.5.12 Uruguay
3.5.13 Colombia
3.5.14 Argentina
3.5.15 Chile
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Growing legalization of cannabis-based CBD products
3.6.1.2 Increasing preference towards cannabis extracts such as oils and tinctures
3.6.1.3 Growing adoption of CBD-based products for treating various medical conditions
3.6.1.4 Rise in the number of retailers selling CBD-based products
3.6.2 Market Restraint Analysis
3.6.2.1 Stringent government regulations
3.6.2.2 Absence of legalization programs in several asian and african countries
3.6.2.3 High cost of CBD in leading markets
3.6.3 Industry Challenges
3.7 Cannabidiol (CBD) - Porter's Analysis
3.8 Cannabidiol (CBD) - PESTEL Analysis
3.9 Opportunity Analysis (2016-2020-2028)
3.10 Import/Export Scenario, by Country
3.11 Product Adoption Pattern Analysis
3.12 Value Chain Analysis
3.12.1 Raw Material Trends
3.12.1.1 Market price evolution of biomass commodity cost (to processor)
3.12.1.2 Manufacturing Trends
3.13 Average Selling Price of Cannabidiol, by Country
3.14 Key End Users
3.14.1 U.S. Market Scenario
3.15 COVID-19 Impact Analysis

Chapter 4 Cannabidiol (CBD) Market: Source Type Estimates & Trend Analysis
4.1 Cannabidiol (CBD) Market Size & Forecasts And Trend Analysis By Source, 2016 - 2028, (USD Million)
4.1.1 Hemp
4.1.2 Marijuana

Chapter 5 Cannabidiol (CBD) Market: Distribution Channel Estimates & Trend Analysis
5.1 Cannabidiol (CBD) Market, By Distribution Channel Analysis
5.2 Business to Business (B2B)
5.3 Business to Consumer (B2C)
5.3.1 Hospital Pharmacies
5.3.2 Online Stores
5.3.3 Retail Stores

Chapter 6 Cannabidiol (CBD) Market: End-use Estimates & Trend Analysis
6.1 Cannabidiol (CBD) Market, By End Use Analysis
6.2 Medical
6.2.1 Chronic Pain
6.2.2 Mental Disorders
6.2.3 Cancer
6.2.4 Others
6.3 Personal Use
6.4 Pharmaceutical
6.5 Wellness
6.5.1 Food & Beverages
6.5.2 Personal Care & Cosmetics
6.5.3 Nutraceuticals

Chapter 7 Cannabidiol (CBD) Market: Regional Estimates & Trend Analysis
7.1 Global Cannabidiol Market Share, By Region, 2020 & 2028

Chapter 8 Competitive Landscape

• Canopy Growth Corporation.
• Aphria, Inc
• Aurora Cannabis
• Maricann, Inc. (Wayland Group Corporation)
• Tilray
• GW Pharmaceuticals, plc
• ABcann Medicinals, Inc.
• Organigram Holding, Inc.
• Tikun Olam
• The Cronos Group
• ENDOCA
• Isodiol International, Inc.
• MEDICAL MARIJUANA, INC.
• Cannoid, LLC
• Elixinol
• Folium Biosciences
• NuLeaf Naturals, LLC
• Pharmahemp d.o.o.

For more information about this report visit https://www.researchandmarkets.com/r/7a2ib8

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com